Thalidomide-induced pneumonitis in a patient with plasma cell leukemia: No recurrence with subsequent lenalidomide therapy.
Pretz
Jennifer
J
Medeiros
Bruno C
BC
D000368:Aged; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D005260:Female; D006801:Humans; D000077269:Lenalidomide; D007952:Leukemia, Plasma Cell / Q000188:drug therapy*; D011657:Pulmonary Eosinophilia / Q000139:chemically induced* / Q000188:drug therapy / Q000517:prevention & control; D055502:Secondary Prevention; D013792:Thalidomide / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D016896:Treatment Outcome
D000970:Antineoplastic Agents; D013792:Thalidomide; D000077269:Lenalidomide